Creative Planning Bio Techne Corp Transaction History

Creative Planning

$103 Billion
Q4 2024

A detailed history of Creative Planning transactions in Bio Techne Corp stock. As of the latest transaction made, Creative Planning holds 22,027 shares of TECH stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,027

Previous 18,513 18.98%

Holding current value

$1.35 Million

Previous $1.48 Million 7.23%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$66.37 - $78.17 $233,224 - $274,689	3,514 Added 18.98%	22,027 $1.59 Million
Q3 2024 Oct 11, 2024	SELL	$70.96 - $82.35 $1.09 Million - $1.27 Million	-15,429 Reduced 45.46%	18,513 $1.48 Million
Q2 2024 Aug 15, 2024	BUY	$62.12 - $84.15 $89,266 - $120,923	1,437 Added 4.42%	33,942 $2.43 Million
Q1 2024 May 10, 2024	BUY	$65.98 - $77.09 $70,202 - $82,023	1,064 Added 3.38%	32,505 $2.29 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $240,112 - $355,509	4,545 Added 16.9%	31,441 $2.43 Million
Q3 2023 Nov 16, 2023	SELL	$67.52 - $89.42 $10,060 - $13,323	-149 Reduced 0.55%	26,896 $1.83 Million
Q2 2023 Jul 21, 2023	SELL	$73.76 - $85.98 $136,013 - $158,547	-1,844 Reduced 6.38%	27,045 $2.21 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $1.09 Million - $1.32 Million	15,188 Added 110.85%	28,889 $2.14 Million
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $867,283 - $3.79 Million	10,751 Added 364.44%	13,701 $1.14 Million
Q3 2022 Nov 03, 2022	BUY	$282.54 - $391.85 $572,708 - $794,279	2,027 Added 219.61%	2,950 $838,000
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $42,592 - $59,353	132 Added 16.69%	923 $320,000
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $31,492 - $43,413	89 Added 12.68%	791 $343,000
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $28,281 - $32,553	62 Added 9.69%	702 $363,000
Q3 2021 Nov 10, 2021	BUY	$444.87 - $538.88 $3,558 - $4,311	8 Added 1.27%	640 $310,000
Q2 2021 Aug 04, 2021	SELL	$387.35 - $450.26 $180,892 - $210,271	-467 Reduced 42.49%	632 $285,000
Q1 2021 Apr 30, 2021	BUY	$314.62 - $411.0 $24,854 - $32,469	79 Added 7.75%	1,099 $420,000
Q4 2020 Jan 29, 2021	SELL	$246.9 - $321.87 $105,920 - $138,082	-429 Reduced 29.61%	1,020 $324,000
Q3 2020 Nov 05, 2020	SELL	$232.22 - $282.96 $54,571 - $66,495	-235 Reduced 13.95%	1,449 $359,000
Q2 2020 Jul 23, 2020	SELL	$185.43 - $279.56 $12,794 - $19,289	-69 Reduced 3.94%	1,684 $445,000
Q1 2020 May 05, 2020	SELL	$161.17 - $221.51 $4,673 - $6,423	-29 Reduced 1.63%	1,753 $332,000
Q4 2019 Jan 30, 2020	SELL	$189.68 - $222.09 $4,931 - $5,774	-26 Reduced 1.44%	1,782 $391,000
Q3 2019 Nov 01, 2019	BUY	$183.56 - $216.72 $4,221 - $4,984	23 Added 1.29%	1,808 $354,000
Q1 2019 Apr 24, 2019	BUY	$136.09 - $200.44 $9,662 - $14,231	71 Added 4.14%	1,785 $354,000
Q4 2018 Feb 01, 2019	SELL	$132.75 - $203.8 $18,452 - $28,328	-139 Reduced 7.5%	1,714 $248,000
Q3 2018 Oct 25, 2018	BUY	$147.44 - $204.11 $9,436 - $13,063	64 Added 3.58%	1,853 $378,000
Q1 2018 Apr 18, 2018	BUY	$131.46 - $151.04 $235,181 - $270,210	1,789 New	1,789 $270,000

Others Institutions Holding TECH

# of Institutions

616

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.4B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Bio Techne Corp Transaction History